2-167184588-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 2P and 13B. PM2BP4_StrongBP6_Very_StrongBP7
The ENST00000409728.5(XIRP2):āc.609T>Cā(p.His203=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000386 in 717,534 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0011 ( 0 hom., cov: 32)
Exomes š: 0.00021 ( 0 hom. )
Consequence
XIRP2
ENST00000409728.5 synonymous
ENST00000409728.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.595
Genes affected
XIRP2 (HGNC:14303): (xin actin binding repeat containing 2) Enables actin filament binding activity. Predicted to be involved in actin cytoskeleton organization and heart development. Predicted to act upstream of or within cardiac muscle tissue morphogenesis; cell-cell junction organization; and ventricular septum development. Colocalizes with focal adhesion and stress fiber. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 2-167184588-T-C is Benign according to our data. Variant chr2-167184588-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 711348.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-167184588-T-C is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.595 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
XIRP2 | NM_152381.6 | c.563-26147T>C | intron_variant | ENST00000409195.6 | |||
XIRP2 | NM_001199143.2 | c.609T>C | p.His203= | synonymous_variant | 4/11 | ||
XIRP2 | NM_001079810.4 | c.563-26147T>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
XIRP2 | ENST00000409195.6 | c.563-26147T>C | intron_variant | 5 | NM_152381.6 |
Frequencies
GnomAD3 genomes AF: 0.00105 AC: 160AN: 152160Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
160
AN:
152160
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000291 AC: 44AN: 151010Hom.: 0 AF XY: 0.000346 AC XY: 28AN XY: 80824
GnomAD3 exomes
AF:
AC:
44
AN:
151010
Hom.:
AF XY:
AC XY:
28
AN XY:
80824
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000207 AC: 117AN: 565256Hom.: 0 Cov.: 0 AF XY: 0.000200 AC XY: 61AN XY: 304976
GnomAD4 exome
AF:
AC:
117
AN:
565256
Hom.:
Cov.:
0
AF XY:
AC XY:
61
AN XY:
304976
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00105 AC: 160AN: 152278Hom.: 0 Cov.: 32 AF XY: 0.00103 AC XY: 77AN XY: 74470
GnomAD4 genome
AF:
AC:
160
AN:
152278
Hom.:
Cov.:
32
AF XY:
AC XY:
77
AN XY:
74470
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
XIRP2-related disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 01, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Dec 13, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at